Financial insights of QNCX

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development	6,845	13,499*	8,083	6,553
Goodwill impairment charge	-	0*	0	0
General and administrative	4,267	5,113*	3,281	3,342
Intangible asset impairment charge	67,808	-	-	-
Fair value adjustment for contingent consideration	-64,330	3,742*	2,066	532
Total operating expenses	14,590	22,353	13,430	10,427
Loss from operations	-14,590	-22,353*	-13,430	-10,427
Fair value adjustment for debt	-12,168	396*	549	-
Fair value adjustment for warrants	-	15,211*	-291	4,464
Warrant issuance costs	-	-457*	42	872
Fair value adjustment for warrants	-31,116	-	-	-
Interest income	160	328*	300	311
Fair value adjustment for long-term debt	-	-	-	501
Other income (expense), net	1,719	617*	-58	-29
Net income (loss) before income tax expense	30,573	-36,559*	-13,488	-15,982
Income tax benefit (expense)	-5,339	3,183*	-46	67
Net income (loss)	35,912	-39,742*	-13,442	-16,049
Foreign currency translation adjustments	-1,135	-662*	125	4,216
Unrealized loss on available-for-sale securities	-5	-56*	12	-17
Total comprehensive income (loss)	34,772	-40,461	-13,305	-11,850

Basic EPS	3.6	-0.815	-0.25	-0.34
Diluted EPS	2.88	-0.815	-0.25	-0.34
Basic Average Shares	9,120,267	49,653,081	53,951,371	46,686,239
Diluted Average Shares	9,190,354	49,653,081	53,951,371	46,686,239

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.